{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:07:08Z","timestamp":1791094028599,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:00:00Z","timestamp":1305158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00270-011-0176-0","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T20:10:50Z","timestamp":1305144650000},"page":"555-562","source":"Crossref","is-referenced-by-count":28,"title":["Switching the Loaded Agent from Epirubicin to Cisplatin: Salvage Transcatheter Arterial Chemoembolization with Drug-eluting Microspheres for Unresectable Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Akihiko","family":"Seki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinich","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"176_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557\u20132576","journal-title":"Gastroenterology"},{"key":"176_CR2","first-page":"101","volume":"35","author":"M Cottone","year":"1988","unstructured":"Cottone M, Turri M, Caltagirone M et al (1988) Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study. Hepatogastroenterology 35:101\u2013103","journal-title":"Hepatogastroenterology"},{"key":"176_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421\u2013430","journal-title":"J Hepatol"},{"key":"176_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429\u2013442","journal-title":"Hepatology"},{"key":"176_CR5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X et al (2002) Arterial embolization or chemoembolization versus systemic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"176_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","volume":"30","author":"L Marelli","year":"2007","unstructured":"Marelli L, Stigliano R, Triantos C et al (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6\u201325","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiology.148.2.6306721","volume":"148","author":"R Yamada","year":"1983","unstructured":"Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397\u2013401","journal-title":"Radiology"},{"issue":"Suppl 7","key":"176_CR8","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.jvir.2009.04.033","volume":"20","author":"DB Brown","year":"2009","unstructured":"Brown DB, Cardella JF, Sacks D et al (2009) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 20(Suppl 7):S219\u2013S226","journal-title":"J Vasc Interv Radiol"},{"key":"176_CR9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00270-007-9255-7","volume":"31","author":"M Satake","year":"2008","unstructured":"Satake M, Uchida H, Arai Y et al (2008) Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 31:756\u2013761","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002709900108","volume":"20","author":"T Sonomura","year":"1997","unstructured":"Sonomura T, Yamada R, Kishi K et al (1997) Dependency of tissue necrosis on gelatin sponge particle size after canine hepatic artery embolization. Cardiovasc Intervent Radiol 20:50\u201353","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474\u2013481","journal-title":"J Hepatol"},{"key":"176_CR12","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","volume":"12","author":"K Hong","year":"2006","unstructured":"Hong K, Khwaja A, Liapi E et al (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563\u20132567","journal-title":"Clin Cancer Res"},{"key":"176_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335\u2013342","journal-title":"J Vasc Interv Radiol"},{"key":"176_CR14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jvir.2010.02.042","volume":"21","author":"O Jordan","year":"2010","unstructured":"Jordan O, Denys A, De Baere T et al (2010) Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol 21:1084\u20131090","journal-title":"J Vasc Interv Radiol"},{"key":"176_CR15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jvir.2010.02.009","volume":"21","author":"N Maeda","year":"2010","unstructured":"Maeda N, Osuga K, Higashihara H et al (2010) In vitro characterization of cisplatin-loaded superabsorbent polymer microspheres designed for chemoembolization. J Vasc Interv Radiol 21:877\u2013881","journal-title":"J Vasc Interv Radiol"},{"key":"176_CR16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-008-9409-2","volume":"31","author":"M Grosso","year":"2008","unstructured":"Grosso M, Vignali C, Quaretti P et al (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicenter study. Cardiovasc Intervent Radiol 31:1141\u20131149","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR17","doi-asserted-by":"crossref","unstructured":"Seki A, Hori S, Kobayashi K et al (2010) Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Intervent Radiol. doi: 10.1007\/s00270-010-9975-y","DOI":"10.1007\/s00270-010-9975-y"},{"key":"176_CR18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00270-009-9694-4","volume":"32","author":"G Poggi","year":"2009","unstructured":"Poggi G, Amatu A, Montagna B et al (2009) OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol 32:1187\u20131192","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00270-008-9369-6","volume":"31","author":"K Osuga","year":"2008","unstructured":"Osuga K, Hori S, Hiraishi K et al (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 31:1108\u20131116","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1872-034X.2008.00338.x","volume":"38","author":"M Yoshikawa","year":"2008","unstructured":"Yoshikawa M, Ono N, Yodono H et al (2008) Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res 38:474\u2013483","journal-title":"Hepatol Res"},{"key":"176_CR21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11604-007-0216-5","volume":"26","author":"N Maeda","year":"2008","unstructured":"Maeda N, Osuga K, Mikami K et al (2008) Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 26:206\u2013212","journal-title":"Radiat Med"},{"key":"176_CR22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00520-009-0744-x","volume":"18","author":"ME Lacouture","year":"2010","unstructured":"Lacouture ME, Maitland ML, Segaert S et al (2010) A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 18:509\u2013522","journal-title":"Support Care Cancer"},{"key":"176_CR23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0168-8278(90)90220-L","volume":"11","author":"C Kalayci","year":"1990","unstructured":"Kalayci C, Johnson PJ, Raby N et al (1990) Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin. J Hepatol 11:349\u2013353","journal-title":"J Hepatol"},{"key":"176_CR24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/(SICI)1097-4652(199606)167:3<434::AID-JCP7>3.0.CO;2-Q","volume":"167","author":"AS Arora","year":"1996","unstructured":"Arora AS, de Groen PC, Croall DE et al (1996) Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase-mediated calpain activation. J Cell Physiol 167:434\u2013442","journal-title":"J Cell Physiol"},{"key":"176_CR25","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO;2-4","volume":"74","author":"JM Chang","year":"1994","unstructured":"Chang JM, Tzeng WS, Pan HB et al (1994) Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer 74:2449\u20132453","journal-title":"Cancer"},{"issue":"suppl","key":"176_CR26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/BF00687096","volume":"31","author":"S Kawai","year":"1992","unstructured":"Kawai S, Okamura J, Ogawa M et al (1992) Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother Pharmacol 31(suppl):S1\u2013S6","journal-title":"Cancer Chemother Pharmacol"},{"key":"176_CR27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11604-010-0436-y","volume":"28","author":"S Sahara","year":"2010","unstructured":"Sahara S, Kawai N, Sato M et al (2010) Prospective comparison of transcatheter arterial chemoembolization with Lipiodol\u2013epirubicin and Lipiodol\u2013cisplatin for treatment of recurrent hepatocellular carcinoma. Jpn J Radiol 28:362\u2013368","journal-title":"Jpn J Radiol"},{"issue":"2 suppl 6","key":"176_CR28","first-page":"S6-38","volume":"24","author":"S Kawai","year":"1997","unstructured":"Kawai S, Tani M, Okamura J et al (1997) Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 24(2 suppl 6):S6-38\u2013S6-45","journal-title":"Semin Oncol"},{"key":"176_CR29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jvir.2009.10.038","volume":"21","author":"A Nicolini","year":"2010","unstructured":"Nicolini A, Martinetti L, Crespi S et al (2010) Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol 21:327\u2013332","journal-title":"J Vasc Interv Radiol"},{"key":"176_CR30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/bjc.1995.134","volume":"71","author":"DW Shen","year":"1995","unstructured":"Shen DW, Akiyama S, Schoenlein P et al (1995) Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. Br J Cancer 71:676\u2013683","journal-title":"Br J Cancer"},{"key":"176_CR31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1872-034X.2009.00606.x","volume":"40","author":"M Moriguchi","year":"2010","unstructured":"Moriguchi M, Takayama T, Nakamura M et al (2010) Phase I\/II study of a fine-powder formulation of cisplatin for transcatheter arterial chemoembolization in hepatocellular carcinoma. Hepatol Res 40:369\u2013375","journal-title":"Hepatol Res"},{"key":"176_CR32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00270-009-9570-2","volume":"32","author":"T Kawaoka","year":"2009","unstructured":"Kawaoka T, Aikata H, Takaki S et al (2009) Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol 32:687\u2013694","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"key":"176_CR34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1872-034X.2008.00466.x","volume":"39","author":"Y Kawamura","year":"2009","unstructured":"Kawamura Y, Ikeda K, Hirakawa M et al (2009) Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin. Hepatol Res 39:346\u2013354","journal-title":"Hepatol Res"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-011-0176-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-011-0176-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-011-0176-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T18:37:17Z","timestamp":1560191837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-011-0176-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1007\/s00270-011-0176-0","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,12]]}}}